Australia markets closed

Medibio Limited (MEB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
At close: 3:59PM AEST

Medibio Limited

100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
61 3 9692 7222

Sector(s):Β Healthcare
Industry:Β Health Information Services
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Mr. Claude SolitarioManaging Director, CEO & Director141.6kN/AN/A
Ms. Melanie Jaye Leydin C.A., B.Bus, CAJoint Company Sec. & Director141.63kN/A1973
Ms. Renee Stanton-HorneOperations & Account Mang.N/AN/AN/A
Ms. Stephanie OttensInvestor Relations DirectorN/AN/AN/A
Mr. Josh PurdyPR DirectorN/AN/AN/A
Dr. Michael PlayerHead of ResearchN/AN/AN/A
Dr. Matthew FlaxHead of Algorithm Devel. TeamN/AN/AN/A
Mr. Archie Defillo M.D.Chief Medical OfficerN/AN/AN/A
Ms. Jennifer SolitarioSr. VP of Corp. HealthN/AN/AN/A
Mr. Massimiliano GrassiHead of Artificial IntelligenceN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Medibio Limited, a health technology company, researches, develops, and commercializes mental health technology to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions in Australia and the United States. It offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. Medibio Limited has a clinical trial agreement with MedBridge Healthcare LLC to support Medibio's sleep analysis of depressive burden (SADB) trial. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is based in Melbourne, Australia.

Corporate governance

Medibio Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.